









Märkte
/
Aktien
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

6.090USD

+0.210+3.57%

Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert

284.30MMarktkapitalisierung

VerlustKGV TTM



Quanterix Corp

6.090

+0.210+3.57%

Übersicht Finanzen Analyse Unternehmen

Übersicht

Finanzen

Analyse

Unternehmen

mehr Informationen über Quanterix Corp Unternehmen

Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Quanterix Corp Informationen



BörsenkürzelQTRX

Name des UnternehmensQuanterix Corp

IPO-datumDec 07, 2017

CEOToloue (Masoud)

Anzahl der mitarbeiter471

WertpapierartOrdinary Share

GeschäftsjahresendeDec 07

Addresse900 Middlesex Turnpike

StadtBILLERICA

BörseNASDAQ OMX - NASDAQ BASIC

LandUnited States of America

Postleitzahl01821

Telefon16173019400

Websitehttps://www.quanterix.com/

BörsenkürzelQTRX

IPO-datumDec 07, 2017

CEOToloue (Masoud)

Führungskräfte von Quanterix Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

282.30K

-1817.00%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

140.51K

+2377.00%

Ms. Karen A. Flynn

Independent Director

49.78K

+23372.00%

Mr. Scott Mendel

Director

31.59K

+25316.00%

Dr. Myla P. Lai-Goldman, M.D.

Director

30.34K

+25316.00%

Mr. Jeffrey Thomas (Jeff) Elliott

Lead Independent Director

27.33K

+23372.00%

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

9.95K

-4395.00%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

Dr. Garret Hampton, Ph.D.

Independent Director

Dr. Alan Sachs, M.D., Ph.D.

Independent Director

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

282.30K

-1817.00%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

140.51K

+2377.00%

Ms. Karen A. Flynn

Independent Director

49.78K

+23372.00%

Mr. Scott Mendel

Director

31.59K

+25316.00%

Dr. Myla P. Lai-Goldman, M.D.

Director

30.34K

+25316.00%

Mr. Jeffrey Thomas (Jeff) Elliott

Lead Independent Director

27.33K

+23372.00%

Umsatzaufteilung

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product revenue

26.15M

0.00%

Service and other revenue

13.95M

0.00%

Collaboration and license revenue

46.00K

0.00%

Nach RegionUSD

Name

Umsatz

Anteil

North America

24.39M

0.00%

EMEA

11.08M

0.00%

Asia Pacific

4.68M

0.00%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product revenue

26.15M

0.00%

Service and other revenue

13.95M

0.00%

Collaboration and license revenue

46.00K

0.00%

Aktionärsstatistik

Aktualisiert: Fri, Nov 21

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.73%

Telegraph Hill Partners

5.36%

Andere

66.95%

Aktionäre

Anteil

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.73%

Telegraph Hill Partners

5.36%

Andere

66.95%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor/Hedge Fund

37.10%

Investment Advisor

22.29%

Hedge Fund

12.26%

Individual Investor

6.30%

Private Equity

5.36%

Research Firm

4.36%

Pension Fund

0.44%

Bank and Trust

0.20%

Family Office

0.13%

Andere

11.56%

Institutionelle Beteiligung



Aktualisiert: Thu, Jan 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q4

383

38.26M

81.91%

-7.44M

2025Q3

384

34.11M

73.41%

-9.53M

2025Q2

391

36.46M

81.18%

-12.95M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Portolan Capital Management, L.L.C.

4.26M

9.12%

+626.23K

+17.23%

Sep 30, 2025

Columbia Threadneedle Investments (UK)

3.14M

6.71%

+8.77K

+0.28%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

2.86M

6.12%

+212.22K

+8.01%

Sep 30, 2025

The Vanguard Group, Inc.

2.65M

5.67%

+118.56K

+4.69%

Sep 30, 2025

Telegraph Hill Partners

2.50M

5.36%

+2.50M

Sep 30, 2025

Walt (David R)

1.86M

3.99%

+2.59K

+0.14%

Oct 01, 2025

Invenomic Capital Management LP

1.39M

2.98%

+248.10K

+21.67%

Sep 30, 2025

William Blair Investment Management, LLC

1.32M

2.82%

+187.30K

+16.60%

Sep 30, 2025

Easterly Investment Partners LLC

1.25M

2.68%

+168.55K

+15.55%

Sep 30, 2025

Millennium Management LLC

1.21M

2.59%

+1.20M

+9880.18%

Sep 30, 2025

Verbundene ETFs



Aktualisiert: Tue, Dec 2

Name

Anteil

Invesco NASDAQ Future Gen 200 ETF

0.63%

iShares Micro-Cap ETF

0.04%

Fidelity Enhanced Small Cap ETF

0.03%

Avantis US Small Cap Equity ETF

0.03%

Invesco RAFI US 1500 Small-Mid ETF

0.02%

iShares Biotechnology ETF

0.02%

Proshares Ultra Russell 2000

0.01%

ProShares UltraPro Russell2000

0.01%

iShares Russell 2000 Value ETF

0.01%

Global X Russell 2000 ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

Anteil0.63%

iShares Micro-Cap ETF

Anteil0.04%

Fidelity Enhanced Small Cap ETF

Anteil0.03%

Avantis US Small Cap Equity ETF

Anteil0.03%

Invesco RAFI US 1500 Small-Mid ETF

Anteil0.02%

iShares Biotechnology ETF

Anteil0.02%

Proshares Ultra Russell 2000

Anteil0.01%

ProShares UltraPro Russell2000

Anteil0.01%

iShares Russell 2000 Value ETF

Anteil0.01%

Global X Russell 2000 ETF

Anteil0.01%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

KeyAI

